Embecta (MEX:EMBC) Inventories, Work In Process: MXN240 Mil (As of Mar. 2026)


MEX:EMBC Embecta Corp MEX:EMBC
53 GF Score
Price MXN497.96
GF Value MXN2,033.47
! 6 Warning Signs
View Full Analysis

What is Embecta Inventories, Work In Process?

Embecta MEX:EMBC 53 Inventories, Work In Process is MXN240 Mil as of Mar. 2026. GuruFocus rates MEX:EMBC with a GF Score™ of 53/100 and a GF Value™ of MXN2,033.47. The stock has 6 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Embecta's work in process for the quarter that ended in Mar. 2026 was MXN240 Mil.

Embecta Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Embecta's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embecta Inventories, Work In Process Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Inventories, Work In Process
Get a 7-Day Free Trial 431.80 112.64 141.09 94.51 214.63

Embecta Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 180.03 248.55 214.63 257.48 239.84
MEX:EMBC
53GF Score
Embecta Corp MEX:EMBC
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embecta Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of MXN240 Mil mean?
Embecta (MEX:EMBC) has a Inventories, Work In Process of MXN240 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Embecta and its competitors.
Is Embecta's Inventories, Work In Process too high?
Embecta's current Inventories, Work In Process is MXN240 Mil. Overall, Embecta has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Embecta's Inventories, Work In Process compare to PDEX and STXS?
Embecta's Inventories, Work In Process of MXN240 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Medical Devices & Instruments company?
A good Inventories, Work In Process depends on the Medical Devices & Instruments industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Embecta and its competitors. Embecta's current Inventories, Work In Process is MXN240 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embecta stock overvalued right now?
Embecta (MEX:EMBC) has a current Inventories, Work In Process of MXN240 Mil. The stock's GF Value™ is MXN2,033.47, compared to a current price of MXN497.96 — trading 75.5% below its estimated fair value. The current Inventories, Work In Process is MXN240 Mil. Embecta's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Embecta (MEX:EMBC), the current Inventories, Work In Process is MXN240 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embecta (MEX:EMBC) Overvalued in 2026?

Based on GuruFocus' analysis, Embecta stock appears to be undervalued. The current stock price of MXN497.96 is trading 75.5% below its estimated GF Value™ of MXN2,033.47.

Key valuation signals for MEX:EMBC:

  • Inventories, Work In Process: MXN240 Mil
  • GF Value™: MXN2,033.47 vs. price of MXN497.96 (75.5% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the MEX:EMBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embecta Business Description

Other Exchanges EMBC:USAJX7:Germany
Address 300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
53GF Score

Get the complete analysis for MEX:EMBC

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN497.96
Price
MXN2,033.47
GF Value